Inotrope use and outcomes among patients hospitalized for heart failure: Impact of systolic blood pressure, cardiac index, and etiology

Journal of Cardiac Failure

Volumn 20, Issue 8, 2014, Pages 593-601

  Kalogeropoulos, Andreas P ^a   Marti, Catherine N ^a   Georgiopoulou, Vasiliki V ^a   Butler, Javed ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

heart failure; Inotropic agents; mortality

Indexed keywords

DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; MILRINONE; CARDIOTONIC AGENT;

ADULT; ARTICLE; CARDIOGENIC SHOCK; DEATH; FEMALE; HEART FAILURE; HEART INDEX; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN PERFUSION; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; VENTRICULAR ASSIST DEVICE; BLOOD PRESSURE; CANADA; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECTS; EPIDEMIOLOGY; FOLLOW UP; HEART FAILURE, SYSTOLIC; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TRENDS; UNITED STATES;

BLOOD PRESSURE; CANADA; CARDIOTONIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; UNITED STATES;

EID: 84905486036     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.05.006     Document Type: Article

References (27)

1. R.D. Kociol, J.R. Horton, G.C. Fonarow, E.M. Reyes, L.K. Shaw, and C.M. O'Connor et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) linked to Medicare claims Circ Heart Fail 4 2011 628 636
2. J. Chen, S.L. Normand, Y. Wang, and H.M. Krumholz National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
3. J.S. Ross, J. Chen, Z. Lin, H. Bueno, J.P. Curtis, and P.S. Keenan et al. Recent national trends in readmission rates after heart failure hospitalization Circ Heart Fail 3 2010 97 103
4. C.M. O'Connor, W.A. Gattis, B.F. Uretsky, K.F. Adams Jr., S.E. McNulty, and S.H. Grossman et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 1999 78 86
5. M.S. Cuffe, R.M. Califf, K.F. Adams Jr., R. Benza, R. Bourge, and W.S. Colucci et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1557
6. U. Elkayam, G. Tasissa, C. Binanay, L.W. Stevenson, M. Gheorghiade, and J.W. Warnica et al. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure Am Heart J 153 2007 98 104
7. G.M. Felker, R.L. Benza, A.B. Chandler, J.D. Leimberger, M.S. Cuffe, and R.M. Califf et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J Am Coll Cardiol 41 2003 997 1003
8. C. Partovian, S.R. Gleim, P.S. Mody, S.X. Li, H. Wang, and K.M. Strait et al. Hospital patterns of use of positive inotropic agents in patients with heart failure J Am Coll Cardiol 60 2012 1402 1409
9. J.I. Goldhaber, and M.A. Hamilton Role of inotropic agents in the treatment of heart failure Circulation 121 2010 1655 1660
10. M. Gheorghiade, M. Vaduganathan, A. Ambrosy, M. Bohm, U. Campia, and J.G. Cleland et al. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure Heart Fail Rev 18 2013 107 122
11. C. Binanay, R.M. Califf, V. Hasselblad, C.M. O'Connor, M.R. Shah, and G. Sopko et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial JAMA 294 2005 1625 1633
12. M.R. Shah, C.M. O'Connor, G. Sopko, V. Hasselblad, R.M. Califf, and L.W. Stevenson Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale Am Heart J 141 2001 528 535
13. D.V. Unverferth, R.D. Magorien, R.P. Lewis, and C.V. Leier Long-term benefit of dobutamine in patients with congestive cardiomyopathy Am Heart J 100 1980 622 630
14. M.J. Likoff, K.T. Weber, V. Andrews, J.S. Janicki, M.S. Sutton, H. Wilson, and M.L. Rocci Jr. Amrinone in the treatment of chronic cardiac failure J Am Coll Cardiol 3 1984 1282 1290
15. A. Elis, T. Bental, O. Kimchi, M. Ravid, and M. Lishner Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study Clin Pharmacol Ther 63 1998 682 685
16. W.T. Abraham, K.F. Adams, G.C. Fonarow, M.R. Costanzo, R.L. Berkowitz, T.H. LeJemtel, and et al In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64
17. P.J. Hauptman, P. Mikolajczak, A. George, C.J. Mohr, R. Hoover, J. Swindle, and M.A. Schnitzler Chronic inotropic therapy in end-stage heart failure Am Heart J 152 2006 1096e1 1096e8
18. A. Delaney, C. Bradford, J. McCaffrey, S.M. Bagshaw, and R. Lee Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials Int J Cardiol 138 2010 281 289
19. M. Gheorghiade, W.T. Abraham, N.M. Albert, B.H. Greenberg, C.M. O'Connor, and L. She et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
20. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, et al American College of Cardiology Foundation/American Heart Association Task Force on Practice Group. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 128 2013 e240 e327
21. A.J. Burger, D.P. Horton, T. LeJemtel, J.K. Ghali, G. Torre, and G. Dennish et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study Am Heart J 144 2002 1102 1118
22. R.L. Benza, J.A. Tallaj, G.M. Felker, K.M. Zabel, W. Kao, R.C. Bourge, and et al The impact of arrhythmias in acute heart failure J Card Fail 10 2004 279 284
23. L.W. Stevenson Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy Circulation 108 2003 492 497
24. L.A. Lehtonen, S. Antila, and P.J. Pentikainen Pharmacokinetics and pharmacodynamics of intravenous inotropic agents Clin Pharmacokinet 43 2004 187 203
25. J.R. Teerlink, M. Metra, V. Zaca, H.N. Sabbah, G. Cotter, M. Gheorghiade, and L.D. Cas Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond Heart Fail Rev 14 2009 243 253
26. M.A. Silver, D.P. Horton, J.K. Ghali, and U. Elkayam Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure J Am Coll Cardiol 39 2002 798 803
27. F. Follath, J.G. Cleland, H. Just, J.G. Papp, H. Scholz, K. Peuhkurinen, and et al Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Lancet 360 2002 196 202